glp-1 cancer risk GLP-1s tied to lower for 10 types of compared with insulin in type 2 diabetes Risk of pancreatic cancer associated
Description
For much of modern medical history, aging was viewed primarily as an unavoidable consequence of time
Long-term follow-up studies - Some trials followed patients for extended periods (up to 3.8 years in the LEADER trial) to assess sustained effects
Six out of 13 included patients prematurely discontinued the study due to adverse events
But that was supposed to end in 2025
And, the best part
Larsen PJ
